摘要
目的探讨与分析尿激酶静脉溶栓治疗急性心肌梗死的疗效和预后。方法选取我院2012年3月至2014年3月期间收治的急性心肌梗死患者100例,随机分为实验组和对照组各50例。对照组进行常规治疗,实验组在对照组基础上进行尿激酶静脉溶栓治疗。分析对比治疗后两组的血管再通率、左室射血分数、心脏事件发生率和住院时间。结果实验组的血管再通率为96.00%,显著高于对照组的80.00%,差异具有统计学意义(P<0.05);实验组的左室射血分数、心脏事件发生率和住院时间均显著低于对照组,差异具有统计学意义(P<0.05)。结论尿激酶静脉溶栓治疗急性心肌梗死具有显著的疗效,且安全性较高,可有效改善患者的临床症状,促进患者的恢复,值得临床应用和推广。
Objective To explore and analyze the curative effect and prognosis of intravenous thrombolysis with urokinase in thetreatment of patients with acute myocardial infarction. Methods A total of 100 cases of patients with acute myocardial infarction admitted toour hospital from March 2012 to March 2014 were selected and randomly divided into experimental group and control group, with 50 casesin each group. The control group was given conventional treatment, while the experimental group was given intravenous thrombolysis withurokinase on this basis. The vascular recanalization rate, left ventricular ejection fraction, incidence of cardiac events and hospitalization timeafter treatment were analyzed and compared between two groups. Results The vascular recanalization rate of experimental group was96.00%, significantly higher than 80.00% of control group, with statistical difference （P 〈0.05）. The left ventricular ejection fraction,incidence of cardiac events and hospitalization time of experimental group were significantly lower than those of control group, withstatistical differences （P〈0.05）. Conclusions The intravenous thrombolysis with urokinase in the treatment of acute myocardial infarctionhas significant curative effect and higher safety, effectively improves the clinical symptoms of patients and promotes patients＇ recovery,which is worthy of clinical promotion and application.
出处
《临床医学工程》
2017年第1期49-50,共2页
Clinical Medicine & Engineering
关键词
尿激酶静脉溶栓
急性心肌梗死
疗效
预后
Intravenous thrombolysis with urokinase
Acute myocardial infarction
Curative effect
Prognosis
